Ovarian Epithelial Tumor
2 clinical trials · Condition
◉ Watch Ovarian Epithelial Tumor
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer (NCT04519151) | Sheba Medical Center | 2021-04-12 |
| Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT01540565) | National Cancer Institute (NCI) | 2012-04-09 |
Track Ovarian Epithelial Tumor automatically
Every clearance here is in the API, with alerts when new ones post.